Skip to main content

Adolescent Fitness Tied to Cardiometabolic Health Years Later

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 23, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 23, 2024 -- Adolescent fitness is inversely associated with the burden of cardiometabolic conditions up to 45 years later, according to a study published online in the January issue of the Scandinavian Journal of Medicine & Science in Sports.

Perttu T.T. Laakso, from the University of Jyväskylä in Finland, and colleagues examined the effect of adolescent cardiorespiratory fitness (CRF), muscular fitness (MF), and speed-agility fitness (SA) on middle-aged cardiometabolic disease risk. The analysis included participants evaluated in adolescence (12 to 19 years) and early (37 to 44 years) or late (57 to 64 years) middle age.

The researchers found that adolescent CRF was inversely associated with middle-age accumulated burden of cardiometabolic conditions, regardless of adiposity, in the whole sample (ß = −0.10) and with elevated blood pressure in women (odds ratio, 0.71). Overall, the associations were stronger in women than men. There was an inverse association of adolescent MF and SA with middle-aged waist circumference, but it did not show as consistent associations as with CRF.

"There have been publicly discussed concerns over how the deteriorating fitness of young people will affect the future labor force. This study gives us some scientific evidence to support that concern," Laakso said in a statement. "Unfortunately, there is little sign of this concern being alleviated, given that the cardiorespiratory fitness level among today’s adolescents has been shown to be significantly lower than that of the adolescents examined in this study."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023

WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.